6-factor prognostic model for patients with advanced urothelial carcinoma
Published 6 years ago • 55 plays • Length 3:05Download video MP4
Download video MP3
Similar videos
-
2:54
a 6-factor prognostic model for urothelial carcinoma patients receiving atezolizumab
-
3:29
prognostic model for patients with metastatic urothelial cancer receiving checkpoint inhibitors
-
4:55
atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma
-
4:41
a new prognostic model for post-platinum pd-l1 inhibitors treatment of urothelial carcinoma
-
2:16
testing the validity of a prognostic model for castration-resistant prostate cancer
-
3:03
comment: urothelial cancer research from asco gu 2018
-
1:03:24
bladder cancer: understanding immune-, targeted-, and antibody-based models for patient care
-
53:23
bladder cancer tests, diagnosis and recurrence
-
4:25
range: docetaxel with or without ramucirumab for metastatic urothelial carcinoma
-
3:57
bladder cancer prognostic model: oxidative stress signatures | aging-us
-
2:55
development and validation of a cimp-associated prognostic model for pancreatic cancer
-
6:59
patterns of recurrence after a radical nephroureterectomy in high-risk upper tract urothelial ca...
-
3:54
prognostic subgroups in advanced bladder cancer
-
1:47
current and upcoming clinical trials in bladder cancer
-
4:38
emerging systemic therapies in rare urothelial cancer variants
-
1:08
dr. balar on pd-l1 testing for urothelial cancer
-
4:28
prognostic factors and treatment selection in rcc
-
1:26
dr. sklar on challenges with clinical trials in bladder cancer